Is CDK9 a promising target for both primary and metastatic osteosarcoma?

Lignende værker

• Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma
  af: Ma, Hangzhan, et al.
  Udgivet: (2018)
• Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma
  af: Heijkants, Renier, et al.
  Udgivet: (2017)
• Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system
  af: Feng, Yong, et al.
  Udgivet: (2014)
• Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma
  af: Bayles, Ian, et al.
  Udgivet: (2019)
• Targeting CDK9 for treatment of colorectal cancer
  af: Rahaman, Muhammed H., et al.
  Udgivet: (2019)